[HTML][HTML] Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from …

M Brisson, É Bénard, M Drolet, JA Bogaards… - The Lancet Public …, 2016 - thelancet.com
Background Modelling studies have been widely used to inform human papillomavirus
(HPV) vaccination policy decisions; however, many models exist and it is not known whether …

Ten years of human papillomavirus vaccination in the United States

LE Markowitz, J Gee, H Chesson, S Stokley - Academic pediatrics, 2018 - Elsevier
Since human papillomavirus (HPV) vaccine was first introduced for females in the United
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed …

[HTML][HTML] Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP)

LE Markowitz, EF Dunne, M Saraiya, HW Chesson… - MMWR Recomm …, 2014 - cdc.gov
This report summarizes the epidemiology of human papillomavirus (HPV) and associated
diseases, describes the licensed HPV vaccines, provides updated data from clinical trials …

Projected association of human papillomavirus vaccination with oropharynx cancer incidence in the US, 2020-2045

Y Zhang, C Fakhry, G D'Souza - JAMA oncology, 2021 - jamanetwork.com
Importance Oropharynx cancer (OPC) incidence has increased for several decades in the
US. It is unclear when and how this trend will be affected by current HPV vaccination trends …

The estimated direct lifetime medical costs of sexually transmitted infections acquired in the United States in 2018

HW Chesson, IH Spicknall, A Bingham… - Sexually transmitted …, 2021 - journals.lww.com
Background We estimated the lifetime medical costs attributable to sexually transmitted
infections (STIs) acquired in 2018, including sexually acquired human immunodeficiency …

[HTML][HTML] Impact of reduced human papillomavirus vaccination coverage rates due to COVID-19 in the United States: a model based analysis

V Daniels, K Saxena, C Roberts, S Kothari, S Corman… - Vaccine, 2021 - Elsevier
Abstract The coronavirus disease 2019 (COVID-19) pandemic has significantly affected
utilization of preventative health care, including vaccines. We aimed to assess HPV …

Recommendations on the use of quadrivalent human papillomavirus vaccine in males--Advisory Committee on Immunization Practices (ACIP), 2011.

EF Dunne, LE Markowitz, H Chesson… - MMWR: Morbidity & …, 2011 - search.ebscohost.com
The article presents recommendations on the use of quadrivalent papillomavirus vaccine
(HVP4) in males by the Advisory Committee on Immunization Practices (ACIP) in 2011. The …

Estimated prevalence and incidence of disease-associated human papillomavirus types among 15-to 59-year-olds in the United States

RM Lewis, JF Laprise, JW Gargano… - Sexually transmitted …, 2021 - journals.lww.com
Methods Prevalence and incidence were estimated for infections with any HPV (any of 37
types detected using Linear Array) and disease-associated HPV, 2 types that cause …

[HTML][HTML] HPV-related oropharyngeal cancer: a review on burden of the disease and opportunities for prevention and early detection

MR Timbang, MW Sim, AF Bewley… - Human vaccines & …, 2019 - Taylor & Francis
The incidence of oropharyngeal cancer (OPC) related to infection with human
papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in …

The role of HPV in head and neck cancer and review of the HPV vaccine

G D'Souza, A Dempsey - Preventive medicine, 2011 - Elsevier
Recent data demonstrate that human papillomavirus also plays a role in cancers other than
ano-genital cancers, specifically head and neck cancers, and non-cancerous conditions …